SINCE publication of the recommended childhood immunization schedule in July 1996,1 the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) have made important changes in recommendations for preventing pertussis and poliomyelitis. Following the licensure of two acellular pertussis vaccines for infants, the advisory groups now recommend use of acellular pertussis vaccine (Tripedia®* or ACELIMUNE®†)‡ as the preferred vaccine for pertussis vaccination for infants beginning at age 2 months. To reduce the risk for vaccine-associated paralytic poliomyelitis (VAPP), recommendations for poliovirus vaccination have expanded the use of inactivated poliovirus vaccine (IPV) by providing three options for poliovirus vaccination (sequential IPV/oral poliovirus vaccine [OPV], all IPV, or all OPV). In addition, a combination Haemophilus influenzae type b (Hib) and hepatitis B vaccine and a combination diphtheria and tetanus toxoids and acellular
Recommended Childhood Immunization Schedule—United States, 1997. JAMA. 1997;277(5):371–372. doi:10.1001/jama.1997.03540290023011
Customize your JAMA Network experience by selecting one or more topics from the list below.